CSF2 and neoplasm: In particular, IL-2 in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by irradiated transgenic xenogeneic cells has been successfully used in dogs with malignant oral melanoma, with 80% of tumour mass loss and a higher percentage of metastasis-free patients [59].